Line 1: |
Line 1: |
| | | |
| + | {| class="wikitable" |
| + | |+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content |
| + | |- |
| + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| + | |- |
| + | |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |Fabiola Quintero-Rivera (FQR) |
| + | | |
| + | | |
| + | |- |
| + | | Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease |
| + | |Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Chronic Neutrophilic Leukemia (CNL)||Disease |
| + | |Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Polycythaemia Vera (PV)||Disease |
| + | |Gokce A. Toruner |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Primary Myelofibrosis (PMF)||Disease |
| + | |T. Niroshi Senaratne |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | |8/4/2020 before submission |
| + | | |
| + | |- |
| + | | Essential Thrombocythaemia (ET)||Disease |
| + | |Rebecca Smith (trainee) + Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete/pending faculty review |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease |
| + | |(trainee), Daynna J.Wolff |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease |
| + | |Thomas Lee |
| + | |8/17/2020 |
| + | |9/7/2020 |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | |'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.''' |
| + | | |
| + | | |
| + | |complete |
| + | | ||FQR |
| + | | |
| + | | |
| + | |- |
| + | | Cutaneous Mastocytosis||Disease |
| + | |Thuy Phung |
| + | | |
| + | |9/1/20 |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Systemic Mastocytosis||Disease |
| + | |Shashi Shetty |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Mast Cell Sarcoma||Disease |
| + | |Thuy Phung +Jordan Lowery |
| + | | |
| + | |9/1/20 |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | |'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden (trainee) +Daynna J.Wolff |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid/Lymphoid Neoplasms with ETV6-JAK2 |
| + | |Disease |
| + | |Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | |NON-WHO ENTITY |
| + | |- |
| + | |Myeloid/Lymphoid Neoplasms with BCR-JAK2 |
| + | |Disease |
| + | |Lauren R. Crowson (trainee) + Daynna J. Wolff |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | |NON-WHO ENTITY |
| + | |- |
| + | |'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Juvenile Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo |
| + | | |
| + | |9/1/20 |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | |'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek? |
| + | | |
| + | |9/1/20 |
| + | |pending |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek |
| + | | |
| + | |9/1/20 |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek |
| + | | |
| + | |9/1/20 |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek |
| + | | |
| + | |9/1/20 |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek |
| + | | |
| + | |9/1/20 |
| + | |PENDING |
| + | | |
| + | |FQR |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) |
| + | | |
| + | | |
| + | |- |
| + | |'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | |01/19/2021-MS (re-review) |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident) |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | |02/01/2021-MS |
| + | | |
| + | |- |
| + | | Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori |
| + | | |
| + | | |
| + | |Complete |
| + | |02/03/2021||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | |02/03/2021-MS |
| + | | |
| + | |- |
| + | | Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | |02/01/2021-MS (re-review) |
| + | | |
| + | |- |
| + | | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee) |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | |Need permission for figure? Update WHO? |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | |Add WHO reference |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg Conboy (Monash Health) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | |Check reference format |
| + | |- |
| + | |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Myelomonocytic Leukemia||Disease||Fei Yang |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Pure Erythroid Leukemia||Disease||Ash Yenamandra |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Basophilic Leukemia||Disease||Ash Yenamandra |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | |Need permission for figure? |
| + | |- |
| + | | Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | |Check reference format |
| + | |- |
| + | | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident) |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |Complete |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident) |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | | Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents) |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||JH / MS |
| + | | |
| + | | |
| + | |- |
| + | |Acute Myeloid Leukemia (AML) with Mutated FLT3 |
| + | |Disease |
| + | |Kay Weng Choy + Greg Conboy (Monash Health) |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |JH / MS |
| + | | |
| + | |NON-WHO ENTITY |
| + | |- |
| + | |Acute Myeloid Leukemia (AML) with NUP214-ABL1 |
| + | |Disease |
| + | |Daynna Wolff+Jessica Snider (Path Resident) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |JH / MS |
| + | | |
| + | |NON-WHO ENTITY |
| + | |- |
| + | |Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 |
| + | |Disease |
| + | |Daynna Wolff+ Paige Woodham (Path Resident) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |JH / MS |
| + | | |
| + | |NON-WHO ENTITY |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||Yassmine Akkari (YA) |
| + | | |
| + | | |
| + | |- |
| + | |'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||Afia Hasnain + Yassmine Akkari |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra + |
| + | |
| + | Lisa Smith + Yassmine Akkari |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | |'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | |Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | |NK-Lymphoblastic Leukemia/Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||YA |
| + | | |
| + | | |
| + | |- |
| + | |B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements |
| + | |Disease |
| + | |Helene Bruyere |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |YA |
| + | | |
| + | |NON-WHO ENTITY |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||Snehal Patel (SP) |
| + | | |
| + | | |
| + | |- |
| + | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Monoclonal B-cell Lymphocytosis||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |B-cell Prolymphocytic Leukemia||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Splenic Marginal Zone Lymphoma||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Hairy Cell Leukemia||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Hairy Cell Leukemia Variant||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |Complete |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Lymphoplasmacytic Lymphoma||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Waldenstrom Macroglobulinemia||Disease||Snehal Patel |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Heavy Chain Diseases'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Mu Heavy Chain Disease||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Gamma Heavy Chain Disease||Disease||Manisha Sutariya |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Alpha Heavy Chain Disease||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Plasma Cell Neoplasms||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Plasmacytoma||Disease|| |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Primary Amyloidosis||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Light Chain and Heavy Chain Deposition Disease||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | POEMS Syndrome||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | TEMPI Syndrome||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Nodal Marginal Zone Lymphoma||Disease||Shivani Golem |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) |
| + | | |
| + | | |
| + | |Complete |
| + | |11/11/2020 |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Follicular Lymphoma||Disease||Ruthann Pfau |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Testicular Follicular Lymphoma||Disease||Ruthann Pfau |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | In Situ Follicular Neoplasia||Disease||Ruthann Pfau |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) |
| + | | |
| + | | |
| + | |Complete |
| + | |8/16/2020 |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid |
| + | | |
| + | |9/30/20 |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Mantle Cell Lymphoma||Disease||Mahsa Khanlari |
| + | | |
| + | |8/15/20 |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | In Situ Mantle Cell Neoplasia||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |Greg Corboy (GC) |
| + | | |
| + | | |
| + | |- |
| + | |T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |EBV-Positive Mucocutaneous Ulcer||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | Fibrin-Associated Diffuse Large B-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Lymphomatoid Granulomatosis||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Intravascular Large B-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |ALK-Positive Large B-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |Complete |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Primary Effusion Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | Multicentric Castleman Disease||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Burkitt Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |Burkitt-Like Lymphoma with 11q Aberration||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | |B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||GC |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||Snehal Patel (SP) |
| + | | |
| + | | |
| + | |- |
| + | |T-cell Prolymphocytic Leukemia||Disease||Michelle Don |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Aggressive NK-cell Leukemia||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Severe Mosquito Bite Allergy||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Adult T-cell Leukemia/Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee) |
| + | | |
| + | | |
| + | |Complete |
| + | |1/21/2021 |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Hepatosplenic T-cell Lymphoma||Disease||Michelle Don |
| + | | |
| + | | |
| + | |Complete |
| + | |1/21/2021 |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Lymphomatoid Papulosis||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | | Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg |
| + | | |
| + | | |
| + | |PENDING |
| + | | ||SP |
| + | | |
| + | | |
| + | |- |
| + | |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | |SP |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | ||Associate Editor?? |
| + | | |
| + | | |
| + | |- |
| + | |Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Nodular Sclerosis Classic Hodgkin Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Mixed Cellularity Classic Hodgkin Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Lymphomas Associated with HIV Infection||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,'' |
| + | |
| + | Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |PENDING |
| + | | |
| + | | |
| + | | |
| + | | |
| + | |- |
| + | |''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Monomorphic B-cell PTLD||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Monomorphic T/NK-cell PTLD||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Histiocytic Sarcoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Langerhans Cell Histiocytosis||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Langerhans Cell Sarcoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Indeterminate Dendritic Cell Tumour||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Interdigitating Dendritic Cell Sarcoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Follicular Dendritic Cell Sarcoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Fibroblastic Reticular Cell Tumor||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Disseminated Juvenile Xanthogranuloma||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | |Erdheim-Chester Disease||Disease|| |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |- |
| + | | || || |
| + | | |
| + | | |
| + | | |
| + | | || |
| + | | |
| + | | |
| + | |} |
| {| class="wikitable sortable" | | {| class="wikitable sortable" |
| |+Gene-Specific Pages | | |+Gene-Specific Pages |